To further contextualize this level of precision, OR values describing the increased odds of breast and ovarian cancer associated with pathogenic genetic mutations BRCA1 and BRCA2 were calculated based on published incidence rates. The gene discussed is BRCA2; the disease is ovarian carcinoma.